BridgeBio Pharma
Price & Volume
Stats
See moreOpen | $82.21 |
Previous Close | $83.08 |
Day Range | $81.50-$82.86 |
52W Range | $42.09-$93.41 |
Market Cap | $16.8B |
Shares Short | 24M |
Financials
See moreRevenue (12 Mos) | $579.9M |
Revenue Growth (YoY) | 66.8% |
Gross Profit (12 Mos) | $551.6M |
Diluted EPS | -$3.74 |
News
See moreYahoo Finance • 2 days ago
Panic grips Ionis Pharmaceuticals investors amid bad news spree
Yahoo Finance • 4 days ago
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 5 days ago
Why AstraZeneca Crashed 8%, Leading Three Rivals, Including Pfizer, To Jump
Yahoo Finance • 5 days ago
Pfizer, Alnylam, BridgeBio gain after late-stage trial setback for Astra/ Ionis
About
CEO | Dr. Neil Kumar Ph.D. |
CFO | Dr. Thomas Trimarchi Ph.D. |
Address | 3160 Porter Drive, Palo Alto, CA, United States, 94304 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 834 |